CRLconf 0.99

relacorilant — CRL

$CORT · CORCEPT THERAPEUTICS INC · hypertension secondary to hypercortisolism

Event date

December 31, 2025

157 days ago

Sponsor runway

5+ yrs

$338.2M liquid

Evidence

“the U.S. Food and Drug Administration has issued a Complete Response Letter regarding the New Drug Application for relacorilant as a treatment for patients with hypertension secondary to hypercortisolism”

Source: 8-K filed 2025-12-31View on EDGAR ↗0001193125-25-338184

Comparable historical crls· last 5 years · same event type

No comparable historical outcomes in our database yet — backfill of past readouts arrives next ingestion cycle.

Recent insider activity· ±90 days

11 insiders · 2 buys · 22 sells

Sell10b5-1

2026-03-25

BELANOFF JOSEPH K

Chief Executive Officer

26,198 @ $50.07$1.31M

Exercise10b5-1

2026-03-20

Guyer William

Chief Development Officer

11,767 @ $21.65$255K

Sell10b5-1

2026-03-20

Guyer William

Chief Development Officer

11,767 @ $36.01$424K

Gift

2026-03-20

WILSON JAMES N

Director

4,000 @ ——

Buy

2026-03-17

BAKER G LEONARD JR

Director

24,218 @ $33.56$813K

Buy

2026-03-17

BAKER G LEONARD JR

Director

75,782 @ $33.00$2.50M

Gift

2026-03-13

WILSON JAMES N

Director

28,000 @ ——

Exercise

2026-03-13

MAHONEY DAVID L

Director

30,000 @ $5.86$176K

Tax

2026-03-13

MAHONEY DAVID L

Director

5,469 @ $32.15$176K

Gift

2026-03-13

MAHONEY DAVID L

Director

24,531 @ ——

Other

2026-03-13

MAHONEY DAVID L

Director

24,531 @ ——

Exercise10b5-1

2026-03-04

Guyer William

Chief Development Officer

8,233 @ $21.65$178K

Sell10b5-1

2026-03-04

Guyer William

Chief Development Officer

8,233 @ $35.99$296K

Tax

2026-03-03

Robb Gary Charles

Chief Business Officer

121 @ $35.97$4K

Tax

2026-03-03

Maduck Sean

See Remarks

110 @ $35.97$4K

Tax

2026-03-03

Lyon Joseph Douglas

See Remarks

89 @ $35.97$3K

Tax

2026-03-03

Mokari Atabak

Chief Financial Officer

96 @ $35.97$3K

Grant

2026-03-02

Mokari Atabak

Chief Financial Officer

397 @ $35.97$14K

Grant

2026-03-02

Robb Gary Charles

Chief Business Officer

499 @ $35.97$18K

Grant

2026-03-02

Maduck Sean

See Remarks

454 @ $35.97$16K

Grant

2026-03-02

Lyon Joseph Douglas

See Remarks

398 @ $35.97$14K

Grant

2026-03-02

Guyer William

Chief Development Officer

498 @ $35.97$18K

Grant

2026-02-27

Robb Gary Charles

Chief Business Officer

140,000 @ ——

Grant

2026-02-27

Lyon Joseph Douglas

See Remarks

140,000 @ ——

Grant

2026-02-27

BELANOFF JOSEPH K

Chief Executive Officer

460,000 @ ——

Grant

2026-02-27

Mokari Atabak

Chief Financial Officer

140,000 @ ——

Grant

2026-02-27

Maduck Sean

See Remarks

140,000 @ ——

Grant

2026-02-27

Hunt Hazel

Chief Scientific Officer

140,000 @ ——

Grant

2026-02-27

Guyer William

Chief Development Officer

140,000 @ ——

Exercise

2026-02-24

WILSON JAMES N

Director

100,000 @ $3.88$388K

Tax

2026-02-24

WILSON JAMES N

Director

10,636 @ $36.48$388K

Gift

2026-02-24

WILSON JAMES N

Director

89,364 @ ——

Other

2026-02-24

WILSON JAMES N

Director

89,364 @ ——

Exercise

2026-02-09

Hunt Hazel

Chief Scientific Officer

150,000 @ $3.88$582K

Tax

2026-02-09

Hunt Hazel

Chief Scientific Officer

77,968 @ $41.31$3.22M

Exercise10b5-1

2026-02-03

Guyer William

Chief Development Officer

20,000 @ $21.65$433K

Sell10b5-1

2026-02-03

Guyer William

Chief Development Officer

20,000 @ $40.87$817K

Exercise

2026-01-27

BAKER G LEONARD JR

Director

30,000 @ $5.86$176K

Exercise

2026-01-27

BAKER G LEONARD JR

Director

25,000 @ $14.08$352K

Other

2026-01-08

Maduck Sean

See Remarks

20,570 @ ——

Other

2026-01-08

Maduck Sean

See Remarks

34,000 @ ——

Gift

2026-01-08

Maduck Sean

See Remarks

20,570 @ ——

Gift

2026-01-08

Maduck Sean

See Remarks

34,000 @ ——

Exercise10b5-1

2026-01-06

Guyer William

Chief Development Officer

20,000 @ $21.65$433K

Sell10b5-1

2026-01-06

Guyer William

Chief Development Officer

20,000 @ $35.18$704K

Gift

2026-01-01

BAKER G LEONARD JR

Director

0 @ ——

Exercise

2025-12-24

Robb Gary Charles

Chief Business Officer

145,000 @ $3.88$563K

Tax

2025-12-24

Robb Gary Charles

Chief Business Officer

80,284 @ $83.59$6.71M

Exercise

2025-12-24

BELANOFF JOSEPH K

Chief Executive Officer

550,000 @ $3.88$2.13M

Tax

2025-12-24

BELANOFF JOSEPH K

Chief Executive Officer

306,846 @ $83.59$25.65M

+ 40 more

Date	Insider	Action	Shares	Price	Value
2026-03-25	BELANOFF JOSEPH KChief Executive Officer	Sell10b5-1	26,198	$50.07	$1.31M
2026-03-20	Guyer WilliamChief Development Officer	Exercise10b5-1	11,767	$21.65	$255K
2026-03-20	Guyer WilliamChief Development Officer	Sell10b5-1	11,767	$36.01	$424K
2026-03-20	WILSON JAMES NDirector	Gift	4,000	—	—
2026-03-17	BAKER G LEONARD JRDirector	Buy	24,218	$33.56	$813K
2026-03-17	BAKER G LEONARD JRDirector	Buy	75,782	$33.00	$2.50M
2026-03-13	WILSON JAMES NDirector	Gift	28,000	—	—
2026-03-13	MAHONEY DAVID LDirector	Exercise	30,000	$5.86	$176K
2026-03-13	MAHONEY DAVID LDirector	Tax	5,469	$32.15	$176K
2026-03-13	MAHONEY DAVID LDirector	Gift	24,531	—	—
2026-03-13	MAHONEY DAVID LDirector	Other	24,531	—	—
2026-03-04	Guyer WilliamChief Development Officer	Exercise10b5-1	8,233	$21.65	$178K
2026-03-04	Guyer WilliamChief Development Officer	Sell10b5-1	8,233	$35.99	$296K
2026-03-03	Robb Gary CharlesChief Business Officer	Tax	121	$35.97	$4K
2026-03-03	Maduck SeanSee Remarks	Tax	110	$35.97	$4K
2026-03-03	Lyon Joseph DouglasSee Remarks	Tax	89	$35.97	$3K
2026-03-03	Mokari AtabakChief Financial Officer	Tax	96	$35.97	$3K
2026-03-02	Mokari AtabakChief Financial Officer	Grant	397	$35.97	$14K
2026-03-02	Robb Gary CharlesChief Business Officer	Grant	499	$35.97	$18K
2026-03-02	Maduck SeanSee Remarks	Grant	454	$35.97	$16K
2026-03-02	Lyon Joseph DouglasSee Remarks	Grant	398	$35.97	$14K
2026-03-02	Guyer WilliamChief Development Officer	Grant	498	$35.97	$18K
2026-02-27	Robb Gary CharlesChief Business Officer	Grant	140,000	—	—
2026-02-27	Lyon Joseph DouglasSee Remarks	Grant	140,000	—	—
2026-02-27	BELANOFF JOSEPH KChief Executive Officer	Grant	460,000	—	—
2026-02-27	Mokari AtabakChief Financial Officer	Grant	140,000	—	—
2026-02-27	Maduck SeanSee Remarks	Grant	140,000	—	—
2026-02-27	Hunt HazelChief Scientific Officer	Grant	140,000	—	—
2026-02-27	Guyer WilliamChief Development Officer	Grant	140,000	—	—
2026-02-24	WILSON JAMES NDirector	Exercise	100,000	$3.88	$388K
2026-02-24	WILSON JAMES NDirector	Tax	10,636	$36.48	$388K
2026-02-24	WILSON JAMES NDirector	Gift	89,364	—	—
2026-02-24	WILSON JAMES NDirector	Other	89,364	—	—
2026-02-09	Hunt HazelChief Scientific Officer	Exercise	150,000	$3.88	$582K
2026-02-09	Hunt HazelChief Scientific Officer	Tax	77,968	$41.31	$3.22M
2026-02-03	Guyer WilliamChief Development Officer	Exercise10b5-1	20,000	$21.65	$433K
2026-02-03	Guyer WilliamChief Development Officer	Sell10b5-1	20,000	$40.87	$817K
2026-01-27	BAKER G LEONARD JRDirector	Exercise	30,000	$5.86	$176K
2026-01-27	BAKER G LEONARD JRDirector	Exercise	25,000	$14.08	$352K
2026-01-08	Maduck SeanSee Remarks	Other	20,570	—	—
2026-01-08	Maduck SeanSee Remarks	Other	34,000	—	—
2026-01-08	Maduck SeanSee Remarks	Gift	20,570	—	—
2026-01-08	Maduck SeanSee Remarks	Gift	34,000	—	—
2026-01-06	Guyer WilliamChief Development Officer	Exercise10b5-1	20,000	$21.65	$433K
2026-01-06	Guyer WilliamChief Development Officer	Sell10b5-1	20,000	$35.18	$704K
2026-01-01	BAKER G LEONARD JRDirector	Gift	0	—	—
2025-12-24	Robb Gary CharlesChief Business Officer	Exercise	145,000	$3.88	$563K
2025-12-24	Robb Gary CharlesChief Business Officer	Tax	80,284	$83.59	$6.71M
2025-12-24	BELANOFF JOSEPH KChief Executive Officer	Exercise	550,000	$3.88	$2.13M
2025-12-24	BELANOFF JOSEPH KChief Executive Officer	Tax	306,846	$83.59	$25.65M

+ 40 more transactions

← All catalysts for $CORT